首页> 外文期刊>Turkish Journal of Geriatrics >ALTMI? YA? üSTü VE ALTI ROMATO?D ARTR?TL? HASTALARDA HASTALIK AKT?V?TES? VE YA?AM KAL?TES?N?N KAR?ILA?TIRILMASI
【24h】

ALTMI? YA? üSTü VE ALTI ROMATO?D ARTR?TL? HASTALARDA HASTALIK AKT?V?TES? VE YA?AM KAL?TES?N?N KAR?ILA?TIRILMASI

机译:六?嗯?前六位罗马人还是D ARTR TL?是否有患者活动的V?测试疾病?和生活的优势

获取原文
           

摘要

Introduction: Aim of this study was to compare disease activity and QoL between patients with rheumatoid arthritis (RA) under and over age 60. Materials and Method: One hundred-fifteen RA patients under age 60 and 51 RA patients ≥60 age were enrolled to the study.%Disease activity was assessed by DAS 28 score and QoL was evaluated by Health Assessment Questionnaire (HAQ) and Short-Form 36 (SF-36). Pain, patients’ and physicians’ global assessment were evaluated by 10 cm Visual Analog Scale (VAS). Results: Ninety (78.2 %) female, 25 (21.7%) male total 115 patients under age 60 with mean age 46.12±9.39 years and 43 (84,3%) female, 8 (15.7%) male total 51 patients over age 60 with a mean age of 66.72±5.18 years sum of 161 RA patients were enrolled to the study. There were statistically significant differences in DAS 28 scores (p=0.036), HAQ (p=0.002), and SF 36-physical health (p=0.034) and SF 36-physical function (p=0.001) scores between groups. Conclusion: RA effects all aspects of QoL, especially the physical scores in the elderly RA patients. During the management of the elderly RA patients, we must be taken in to the consideration have worse QoL and disease activity scores in addition to factors like polypharmacy, comorbidity.
机译:简介:本研究的目的是比较60岁以下及60岁以上的类风湿关节炎(RA)患者的疾病活动性和QoL。材料与方法:纳入115名60岁以下的RA患者和51名≥60岁的RA患者。通过DAS 28评分评估疾病活性的百分比,并通过健康评估问卷(HAQ)和简短表格36(SF-36)评估QoL。疼痛,患者和医生的整体评估通过10厘米视觉模拟量表(VAS)进行评估。结果:90名(78.2%)女性,25名(21.7%)男性共115名60岁以下的患者,平均年龄为46.12±9.39岁,女性43名(84.3%),女性8名(15.7%)男,共51名60岁以上的患者该研究共纳入161名RA患者,平均年龄为66.72±5.18岁。两组之间DAS 28得分(p = 0.036),HAQ(p = 0.002)和SF 36身体健康(p = 0.034)和SF 36身体功能(p = 0.001)得分存在统计学差异。结论:RA影响QoL的各个方面,尤其是老年RA患者的身体得分。在老年RA患者的治疗过程中,除了多药,合并症等因素外,我们还必须考虑到QoL和疾病活动评分较差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号